Karyopharm Therapeutics Inc. short interest in 2021
In 2021, Karyopharm Therapeutics Inc.'s disclosed short interest ran from 21.55% of shares outstanding on 15 Jan 2021 to 16.05% on 31 Dec 2021, a change of -5.50 percentage points. The year's high was 22.45% on 26 Feb 2021 and its low 16.05% on 31 Dec 2021, averaging 19.22% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.16 days on 30 Jul 2021. Full history: Karyopharm Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 21.55% (15 Jan 2021)
- End of year
- 16.05% (31 Dec 2021)
- Change
- -5.50 pp
- High
- 22.45% (26 Feb 2021)
- Low
- 16.05% (31 Dec 2021)
- Average
- 19.22%
- Highest days to cover
- 18.16 (30 Jul 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 21.55% | 6.69 | results (8-K) |
| 29 Jan 2021 | 19.28% | 5.09 | |
| 12 Feb 2021 | 21.39% | 4.40 | results (8-K) |
| 26 Feb 2021 | 22.45% | 7.63 | 10-K filed |
| 15 Mar 2021 | 20.88% | 6.89 | |
| 31 Mar 2021 | 20.74% | 7.99 | |
| 15 Apr 2021 | 21.31% | 13.86 | |
| 30 Apr 2021 | 19.81% | 11.10 | |
| 14 May 2021 | 19.79% | 5.99 | results (8-K), 10-Q filed |
| 28 May 2021 | 18.26% | 12.55 | |
| 15 Jun 2021 | 19.23% | 9.90 | |
| 30 Jun 2021 | 20.04% | 10.40 | |
| 15 Jul 2021 | 20.03% | 13.90 | |
| 30 Jul 2021 | 19.94% | 18.16 | |
| 13 Aug 2021 | 18.59% | 4.86 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 18.45% | 9.07 | |
| 15 Sep 2021 | 17.47% | 10.33 | |
| 30 Sep 2021 | 19.12% | 10.38 | |
| 15 Oct 2021 | 17.68% | 13.07 | |
| 29 Oct 2021 | 17.36% | 12.62 | |
| 15 Nov 2021 | 17.13% | 3.19 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 16.83% | 7.41 | |
| 15 Dec 2021 | 17.85% | 6.06 | |
| 31 Dec 2021 | 16.05% | 5.12 |
See also: Karyopharm Therapeutics Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.